These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
139 related articles for article (PubMed ID: 23430138)
1. Formulation and in vitro and in vivo evaluation of film-coated montelukast sodium tablets using Opadry® yellow 20A82938 on an industrial scale. Zaid AN; Natour S; Qaddomi A; Abu Ghoush A Drug Des Devel Ther; 2013; 7():83-91. PubMed ID: 23430138 [TBL] [Abstract][Full Text] [Related]
2. Formulation and bioequivalence of two Valsartan/Amlodipine immediate release tablets after a single oral administration. Zaid AN; Natur S; Qaddomi A; Abualhasan M; Al-Ramahi R; Shraim N; Khammash S; Jaradat N Pak J Pharm Sci; 2014 Jul; 27(4):755-62. PubMed ID: 25015436 [TBL] [Abstract][Full Text] [Related]
3. Bioequivalence studies of film-coated tablet and chewable tablet generic formulations of montelukast in healthy volunteers. Cánovas M; Arcabell M; Martínez G; Canals M; Cabré F Arzneimittelforschung; 2011; 61(11):610-6. PubMed ID: 22232849 [TBL] [Abstract][Full Text] [Related]
4. Relative bioavailability of two 5-mg montelukast sodium chewable tablets: a single dose, randomized, open-label, 2-period crossover comparison in healthy korean adult male volunteers. Kim HT; Song YK; Lee SD; Park Y; Kim CK Arzneimittelforschung; 2012 Mar; 62(3):123-7. PubMed ID: 22407900 [TBL] [Abstract][Full Text] [Related]
5. Bioequivalence study of montelukast tablets in healthy Pakistani volunteers. Abbas M; Khan AM; Amin S; Riffat S; Ashraf M; Waheed N Pak J Pharm Sci; 2013 Mar; 26(2):255-9. PubMed ID: 23455193 [TBL] [Abstract][Full Text] [Related]
6. Investigation of the bioequivalence of montelukast chewable tablets after a single oral administration using a validated LC-MS/MS method. Zaid AN; Abualhasan MN; Watson DG; Mousa A; Ghazal N; Bustami R Drug Des Devel Ther; 2015; 9():5315-21. PubMed ID: 26451086 [TBL] [Abstract][Full Text] [Related]
7. To Maintain Formulation Composition Similarity of Coated Tablets of Different Strengths: Should Coating be Based on Core Tablet Weight or Surface Area? Reddy JP; Vyas G; Patel R; Rana S; Mansuri N; Dimuthu J; Shah T; Desai D Pharm Res; 2020 Sep; 37(10):201. PubMed ID: 32968862 [TBL] [Abstract][Full Text] [Related]
8. [Bioequivalence study of montelukast 5 mg chewable tablets]. Medina AP; Olaya FJ; Navas MP; Tilano AM; Muñoz E Biomedica; 2012 Sep; 32(3):399-407. PubMed ID: 23715188 [TBL] [Abstract][Full Text] [Related]
9. Novel montelukast sodium-loaded stable oral suspension bioequivalent to the commercial granules in rats. Kim DW; Kim YH; Yousaf AM; Kim DS; Kwon TK; Park JH; Kim YI; Park JH; Jin SG; Kim KS; Cho KH; Li DX; Kim JO; Yong CS; Woo JS; Choi HG Arch Pharm Res; 2016 Apr; 39(4):539-546. PubMed ID: 26983932 [TBL] [Abstract][Full Text] [Related]
10. Bioequivalence studies for two different strengths of montelukast in healthy volunteers: 10 mg film-coated tablets and 5 mg chewable tablets. Pedroso P; Almeida S; Filipe A; Neves RI; Boudreault S; Jiménez C Drug Res (Stuttg); 2013 Sep; 63(9):477-83. PubMed ID: 23780502 [TBL] [Abstract][Full Text] [Related]
11. Formulation and evaluation of a montelukast sodium orally disintegrating tablet with a similar dissolution profile as the marketed product. Chen Y; Feng T; Li Y; Du B; Weng W Pharm Dev Technol; 2017 Mar; 22(2):168-172. PubMed ID: 26654222 [TBL] [Abstract][Full Text] [Related]
12. Characterization of tablet film coatings using a laser-induced breakdown spectroscopic technique. Madamba MC; Mullett WM; Debnath S; Kwong E AAPS PharmSciTech; 2007 Dec; 8(4):E103. PubMed ID: 18181524 [TBL] [Abstract][Full Text] [Related]
13. Film-coated matrix mini-tablets for the extended release of a water-soluble drug. Mohamed FA; Roberts M; Seton L; Ford JL; Levina M; Rajabi-Siahboomi AR Drug Dev Ind Pharm; 2015 Apr; 41(4):623-30. PubMed ID: 24564797 [TBL] [Abstract][Full Text] [Related]
14. Aqueous coating dispersion (pseudolatex) of zein improves formulation of sustained-release tablets containing very water-soluble drug. Li XN; Guo HX; Heinamaki J J Colloid Interface Sci; 2010 May; 345(1):46-53. PubMed ID: 20129615 [TBL] [Abstract][Full Text] [Related]
15. Performance Evaluation of Montelukast Pediatric Formulations: Part II - a PBPK Modelling Approach. Guimarães M; Vertzoni M; Fotaki N AAPS J; 2022 Jan; 24(1):27. PubMed ID: 35013803 [TBL] [Abstract][Full Text] [Related]
16. Development and stability evaluation of enteric coated Diclofenac sodium tablets using Sureteric. Zaid AN Pak J Pharm Sci; 2012 Jan; 25(1):59-64. PubMed ID: 22186310 [TBL] [Abstract][Full Text] [Related]
17. Formulation and bioequivalence of two sildenafil 50 mg film-coated tablets after a single oral administration. Zaid AN; Ramahi RA; Bustami R; Mousa A Int J Clin Pharmacol Ther; 2015 Aug; 53(8):697-704. PubMed ID: 25997550 [TBL] [Abstract][Full Text] [Related]
18. Bioequivalence study of two risedronate sodium film-coated tablet formulations in healthy volunteers. Simanjuntak R; Setiawati E; Yunaidi DA; Handayani LR; Setiawati A; Utami BS; Rosa TA; Sholeh AB Drug Res (Stuttg); 2014 Mar; 64(3):136-40. PubMed ID: 24002927 [TBL] [Abstract][Full Text] [Related]
19. In Vivo Predictive Dissolution Testing of Montelukast Sodium Formulations Administered with Drinks and Soft Foods to Infants. Martir J; Flanagan T; Mann J; Fotaki N AAPS PharmSciTech; 2020 Oct; 21(7):282. PubMed ID: 33051713 [TBL] [Abstract][Full Text] [Related]
20. Combined site-specific release retardant mini-matrix tablets (C-SSRRMT) for extended oral delivery of dexketoprofen trometamol: Sweed NM; Basalious EB; Nour SA Drug Dev Ind Pharm; 2019 Nov; 45(11):1777-1787. PubMed ID: 31418598 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]